Johnson & Johnson Reports Strong Q2, Solid Growth in Vision Care
NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ), a global healthcare company, announced its second-quarter 2026 financial results yesterday, reporting a 6.6 percent increase in sales to $25.3 billion.…

